Powder: -20°C for 3 years | In solvent: -80°C for 1 year
α-Glucosidase-IN-31 (compound R1) is a potent oral α-Glucosidase inhibitor with an IC50 of 10.1 μM, demonstrating significant blood glucose reduction and antidiabetic activity [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | α-Glucosidase-IN-31 (compound R1) is a potent oral α-Glucosidase inhibitor with an IC50 of 10.1 μM, demonstrating significant blood glucose reduction and antidiabetic activity [1]. |
In vivo | α-Glucosidase-IN-31 (compound R1; 10 mg/kg; oral gavage; for 15 days) significantly reduces blood glucose levels in diabetic mice [1]. |
Molecular Weight | 290.36 |
Formula | C18H18N4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
α-Glucosidase-IN-31 Metabolism Glucosidase inhibitor inhibit